ROIV
Roivant Sciences Ltd.
NASDAQ · GBHealthcareBiotechnology
$34.47-0.12%
Price as of Jul 20, 2026
ROIV ownership
Roivant Sciences Ltd. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
24
Net (3m)
-$193.1M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price +26.7%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 2, 2026 | Fitzgerald Meghandirector | Sell | 10,000 | $34.90 |
| Jul 2, 2026 | Fitzgerald Meghandirector | Option | 10,000 | $8.80 |
| Jul 2, 2026 | Gline Matthewdirector, officer: CEO | Tax | 76,171 | $35.39 |
| Jul 2, 2026 | Torti Frankofficer: President and Vant Chair | Tax | 40,310 | $35.39 |
| Jul 2, 2026 | Sukhatme Mayukhdirector, officer: President & CIO | Tax | 46,878 | $35.39 |
| Jul 1, 2026 | Epperly Melissa B,director | Sell | 2,748 | $34.71 |
| Jul 1, 2026 | Epperly Melissa B,director | Option | 17,750 | $4.46 |
| Jul 1, 2026 | Epperly Melissa B,director | Sell | 15,002 | $34.32 |
| Jun 30, 2026 | MANCHESTER KEITH Sdirector | Sell | 12,380 | $35.28 |
| Jun 30, 2026 | QVT Financial LPother: Director by Deputization | Sell | 12,380 | $35.28 |
| Jun 30, 2026 | QVT Financial LPother: Director by Deputization | Sell | 600,000 | $34.59 |
| Jun 30, 2026 | MANCHESTER KEITH Sdirector | Sell | 200,000 | $34.44 |
| Jun 30, 2026 | QVT Financial LPother: Director by Deputization | Sell | 200,000 | $34.44 |
| Jun 30, 2026 | QVT Financial LPother: Director by Deputization | Sell | 300,783 | $33.92 |
| Jun 30, 2026 | Gold Daniel Allendirector | Sell | 300,783 | $33.92 |
| Jun 30, 2026 | Gold Daniel Allendirector | Sell | 200,000 | $34.44 |
| Jun 30, 2026 | MANCHESTER KEITH Sdirector | Sell | 325,000 | $34.07 |
| Jun 30, 2026 | Gold Daniel Allendirector | Sell | 325,000 | $34.07 |
| Jun 30, 2026 | MANCHESTER KEITH Sdirector | Sell | 600,000 | $34.59 |
| Jun 30, 2026 | QVT Financial LPother: Director by Deputization | Sell | 325,000 | $34.07 |
| Jun 30, 2026 | Gold Daniel Allendirector | Sell | 12,380 | $35.28 |
| Jun 30, 2026 | MANCHESTER KEITH Sdirector | Sell | 300,783 | $33.92 |
| Jun 30, 2026 | Gold Daniel Allendirector | Sell | 600,000 | $34.59 |
| Jun 29, 2026 | Sukhatme Mayukhdirector, officer: President & CIO | Sell | 500,000 | $34.13 |
| Jun 29, 2026 | Sukhatme Mayukhdirector, officer: President & CIO | Option | 500,000 | $3.85 |
| Jun 26, 2026 | Venker Ericofficer: President & Immunovant CEO | Sell | 153,766 | $33.05 |
| Jun 26, 2026 | Venker Ericofficer: President & Immunovant CEO | Sell | 46,234 | $33.51 |
| Jun 26, 2026 | Venker Ericofficer: President & Immunovant CEO | Option | 200,000 | $3.85 |
| Jun 23, 2026 | Pulik Richardofficer: CFO | Tax | 2,129 | $31.43 |
| Jun 23, 2026 | Humes Jenniferofficer: Chief Accounting Officer | Tax | 3,582 | $31.43 |
Source: ROIV SEC Form 4 filings, latest Jul 2, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their ROIV positions over the last 6 months (SEC Form 13F).
Increased
333
New positions
191
Reduced
236
Sold out
91
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 78.0M | May 15, 2026 |
| FMR LLC | Increased | 65.8M | Feb 17, 2026 |
| MORGAN STANLEY | Increased | 58.4M | Feb 13, 2026 |
| MORGAN STANLEY | Reduced | 51.8M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 44.3M | May 13, 2026 |
| VANGUARD GROUP INC | Increased | 42.1M | Jan 29, 2026 |
| BLACKROCK, INC. | Increased | 41.2M | Feb 12, 2026 |
| QVT FINANCIAL LP | Reduced | 26.4M | Feb 13, 2026 |
| QVT FINANCIAL LP | Reduced | 25.2M | May 15, 2026 |
| UBS GROUP AG | Increased | 22.6M | May 5, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 20.7M | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 19.8M | May 8, 2026 |
| UBS GROUP AG | Increased | 18.4M | Jan 29, 2026 |
| STATE STREET CORP | Reduced | 17.4M | Feb 13, 2026 |
| SB INVESTMENT ADVISERS (UK) LTD | Reduced | 16.4M | Feb 18, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.